SV1996000015A - Derivados de n-(3-benzofuranil)urea - Google Patents

Derivados de n-(3-benzofuranil)urea

Info

Publication number
SV1996000015A
SV1996000015A SV1996000015A SV1996000015A SV1996000015A SV 1996000015 A SV1996000015 A SV 1996000015A SV 1996000015 A SV1996000015 A SV 1996000015A SV 1996000015 A SV1996000015 A SV 1996000015A SV 1996000015 A SV1996000015 A SV 1996000015A
Authority
SV
El Salvador
Prior art keywords
derivatives
benzofuranil
urea
substituted
suzyzanes
Prior art date
Application number
SV1996000015A
Other languages
English (en)
Inventor
Gabriele Braunlich
Rudiger Fischer
Mazen Es-Sayed
Rolf Henning
Michael Sperzel
Karl-Heinz Schlemmer
Ulrich Nielsch
Stephen Tudhope
Graham Sturton
Trevor S Abram
Mary F Fitzgerald
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of SV1996000015A publication Critical patent/SV1996000015A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/86—Benzo [b] furans; Hydrogenated benzo [b] furans with an oxygen atom directly attached in position 7
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • AIDS & HIV (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
  • Cosmetics (AREA)

Abstract

LA PRESENTE INVENCION SE RELACIONA CON LA PREPARACIO DE DERIVADOS DE N-83-BENZOFURANIL)UREA, HACIENDO REACCIONAR BENZOFURANO 3-AMINOSUSTITUIDOS CON ISOCIANATOS O TIOISOCIANATOS SUSTITUIDOS APROPIADOS, LOS DERIVADOS DE N-(3-BENZOFURANIL)UREA SE PUEDEN USAR COMO INGREDIENTES ACTIVOS DE MEDICAMENTOS CONCRETAMENTE PARA EL TRATAMIENTO DE PROCESOS INFLAMATORIOD AGUDOS Y CRONICOS.
SV1996000015A 1995-03-06 1996-03-06 Derivados de n-(3-benzofuranil)urea SV1996000015A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9504460.8A GB9504460D0 (en) 1995-03-06 1995-03-06 N-(3-Benzofuranyl)urea-derivatives

Publications (1)

Publication Number Publication Date
SV1996000015A true SV1996000015A (es) 1997-02-17

Family

ID=10770709

Family Applications (1)

Application Number Title Priority Date Filing Date
SV1996000015A SV1996000015A (es) 1995-03-06 1996-03-06 Derivados de n-(3-benzofuranil)urea

Country Status (42)

Country Link
US (2) US6399657B1 (es)
EP (1) EP0731099B1 (es)
JP (1) JP3204901B2 (es)
KR (2) KR100405579B1 (es)
CN (2) CN1134419A (es)
AR (1) AR002710A1 (es)
AT (1) ATE193704T1 (es)
BG (2) BG62732B1 (es)
BR (1) BR9600930A (es)
CA (1) CA2170824A1 (es)
CO (1) CO4370145A1 (es)
CZ (1) CZ66796A3 (es)
DE (1) DE69608721T2 (es)
DK (1) DK0731099T3 (es)
DZ (1) DZ1998A1 (es)
EE (1) EE03921B1 (es)
ES (1) ES2147320T3 (es)
FI (1) FI960998A (es)
GB (1) GB9504460D0 (es)
GR (1) GR3034240T3 (es)
HK (1) HK1013285A1 (es)
HR (1) HRP960071B1 (es)
HU (1) HU222282B1 (es)
IL (1) IL117349A (es)
MA (1) MA23815A1 (es)
MY (1) MY117526A (es)
NO (1) NO313672B1 (es)
NZ (1) NZ286107A (es)
PE (1) PE43597A1 (es)
PL (1) PL189206B1 (es)
PT (1) PT731099E (es)
RO (1) RO116622B1 (es)
RU (1) RU2162845C2 (es)
SI (1) SI0731099T1 (es)
SK (1) SK281817B6 (es)
SV (1) SV1996000015A (es)
TN (1) TNSN96035A1 (es)
TR (1) TR199600177A2 (es)
TW (1) TW336934B (es)
UA (1) UA46714C2 (es)
YU (1) YU49359B (es)
ZA (1) ZA961774B (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9312853D0 (en) 1993-06-22 1993-08-04 Euro Celtique Sa Chemical compounds
US5922751A (en) 1994-06-24 1999-07-13 Euro-Celtique, S.A. Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
US5591776A (en) 1994-06-24 1997-01-07 Euro-Celtique, S.A. Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
GB9504460D0 (en) * 1995-03-06 1995-04-26 Bayer Ag N-(3-Benzofuranyl)urea-derivatives
US6166041A (en) 1995-10-11 2000-12-26 Euro-Celtique, S.A. 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
GB9525262D0 (en) * 1995-12-11 1996-02-07 Bayer Ag Heterocyclylcarbonyl substituted benzofuranyl-ureas
US6075016A (en) 1996-04-10 2000-06-13 Euro-Celtique S.A. 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity
GB9614718D0 (en) 1996-07-12 1996-09-04 Bayer Ag 3-ureido-pyridofurans and -pyridothiophenes
JPH10168095A (ja) 1996-12-10 1998-06-23 Cci Corp 炎症性腸疾患予防および治療剤
WO2000027802A1 (en) * 1998-11-12 2000-05-18 Ariad Pharmaceuticals, Inc. Bicyclic signal transduction inhibitors, compositions containing them & uses thereof
GB2350109A (en) * 1999-05-17 2000-11-22 Bayer Ag Pharmaceutically active benzofuranyl sulfonates
GB2350112A (en) * 1999-05-17 2000-11-22 Bayer Ag Pharmaceutically active cycloalkyl ketones
GB2350110A (en) * 1999-05-17 2000-11-22 Bayer Ag Pharmaceutically active benzofurans
GB2350111A (en) * 1999-05-17 2000-11-22 Bayer Ag Oligohydroxyl substituted 3-urea-benzofuran and pyridofuran derivatives
US7144885B2 (en) 2002-02-22 2006-12-05 Bayer Pharmaceuticals Corporation Fused tricyclic heterocycles useful for treating hyper-proliferative disorders
MXPA04007391A (es) * 2002-02-22 2004-10-11 Bayer Pharmaceuticals Corp Heterociclos triciclicos fusionados utiles para el tratamiento de padecimientos hiper-proliferantes.
JP4206382B2 (ja) * 2002-11-19 2009-01-07 アキリオン ファーマシューティカルズ，インコーポレーテッド 置換されたアリールチオウレアおよび関連化合物；ウイルス複製のインヒビター
US7186725B2 (en) 2003-01-03 2007-03-06 Genzyme Corporation Anti-inflammatory compositions and methods
TW200528459A (en) * 2004-01-06 2005-09-01 Achillion Pharmaceuticals Inc Azabenzofuran substituted thioureas; inhibitors of viral replication
TW200600492A (en) * 2004-05-18 2006-01-01 Achillion Pharmaceuticals Inc Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
WO2006137350A1 (ja) * 2005-06-22 2006-12-28 Kissei Pharmaceutical Co., Ltd. 新規なフロピリジン誘導体、それを含有する医薬組成物およびそれらの用途
ME01901B (me) 2006-07-05 2014-12-20 Astrazeneca Ab Kombinacija inhibitora HMG-CoA reduktaze atorvastatina ili simvastatina sa fosfodiesteraza 4 inhibitorom, kao što je roflumilast za lečenje inflamatornih pulmonarnih oboljenja
US20140057978A1 (en) 2011-03-17 2014-02-27 Algiax Pharmaceuticals Gmbh Novel use of benzofuranylsulfonates
WO2013156232A1 (en) * 2012-04-16 2013-10-24 Algiax Pharmaceuticals Gmbh Use of benzofuranylsulfonates in neuropathic pain
CA2941782C (en) 2014-03-18 2022-08-23 Algiax Pharmaceuticals Gmbh 2-cyano-3-cyclopropyl-3-hydroxy-n-aryl-thioacrylamide derivatives
EP3165224A1 (en) 2015-11-09 2017-05-10 Albert-Ludwigs-Universität Freiburg Use of pde4 inhibitors for the prophylaxis and/or therapy of dyslipoproteinaemia and related disorders
WO2017089347A1 (en) 2015-11-25 2017-06-01 Inserm (Institut National De La Sante Et De La Recherche Medicale) Methods and pharmaceutical compositions for the treatment of braf inhibitor resistant melanomas
JP6788966B2 (ja) * 2015-12-24 2020-11-25 丸善製薬株式会社 化粧料
EP4020024A1 (en) 2020-12-22 2022-06-29 Paul Scherrer Institut Method for producing high aspect ratio fan-shaped optics

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA824343B (en) * 1981-07-01 1983-04-27 Upjohn Co Pyridinyl- and imidazolyl-benzofurane and benzothiophenes
US4933351A (en) * 1983-10-31 1990-06-12 Merck Frosst Canada, Inc. Benzofuran 2-carbox amides useful as inhibitors of leukoriene biosynthesis
US4822803A (en) * 1983-10-31 1989-04-18 Merck Frosst Canada, Inc. Benzofuran 2-carboxylic acid hydrazides useful as inhibitors of leukotriene biosynthesis
US4663347A (en) 1983-10-31 1987-05-05 Merck Frosst Canada, Inc. Benzofuran 2-carboxylic acid esters useful as inhibitors of leukotriene biosynthesis
EP0146243A1 (en) * 1983-10-31 1985-06-26 Merck Frosst Canada Inc. Lipoxygenase inhibitors
US5087638A (en) * 1984-06-20 1992-02-11 Merck Frosst Canada, Inc. Benzofuran derivatives
GB9200623D0 (en) * 1992-01-13 1992-03-11 Bayer Ag Benzofuranyl and thiophenyl-methylthio-alkanecarboxylic acid derivatives
GB9309324D0 (en) * 1993-05-06 1993-06-16 Bayer Ag Venzofuranyl-and-thiophenyl-alkanecarboxyclic acids derivatives
GB9504460D0 (en) * 1995-03-06 1995-04-26 Bayer Ag N-(3-Benzofuranyl)urea-derivatives

Also Published As

Publication number Publication date
US6677372B2 (en) 2004-01-13
UA46714C2 (uk) 2002-06-17
HRP960071B1 (en) 2001-04-30
ATE193704T1 (de) 2000-06-15
RU2162845C2 (ru) 2001-02-10
BG62732B1 (bg) 2000-06-30
DK0731099T3 (da) 2000-09-25
SI0731099T1 (en) 2000-08-31
HU222282B1 (hu) 2003-05-28
ZA961774B (en) 1996-09-17
AU4582896A (en) 1996-09-19
HU9600549D0 (en) 1996-04-29
FI960998A0 (fi) 1996-03-04
CN1313284A (zh) 2001-09-19
TR199600177A2 (tr) 1996-10-21
EE9600030A (et) 1996-10-15
KR100405579B1 (ko) 2004-03-19
NO313672B1 (no) 2002-11-11
CA2170824A1 (en) 1996-09-07
YU49359B (sh) 2005-09-19
HRP960071A2 (en) 1997-12-31
RO116622B1 (ro) 2001-04-30
KR960034194A (ko) 1996-10-22
CN1176651C (zh) 2004-11-24
HUP9600549A3 (en) 1998-04-28
CZ66796A3 (en) 1996-09-11
ES2147320T3 (es) 2000-09-01
FI960998A (fi) 1996-09-07
DE69608721T2 (de) 2000-10-05
MY117526A (en) 2004-07-31
BR9600930A (pt) 1997-12-30
EP0731099B1 (en) 2000-06-07
PT731099E (pt) 2000-11-30
PL313070A1 (en) 1996-09-16
PL189206B1 (pl) 2005-07-29
SK281817B6 (sk) 2001-08-06
HK1013285A1 (en) 1999-08-20
EP0731099A1 (en) 1996-09-11
JPH08253466A (ja) 1996-10-01
DZ1998A1 (fr) 2002-07-20
BG100396A (bg) 1996-12-31
CN1134419A (zh) 1996-10-30
TW336934B (en) 1998-07-21
AU705667B2 (en) 1999-05-27
HUP9600549A2 (en) 1997-07-28
DE69608721D1 (de) 2000-07-13
KR100438633B1 (ko) 2004-07-02
YU13396A (sh) 1999-06-15
MA23815A1 (fr) 1996-10-01
TNSN96035A1 (fr) 2005-03-15
US6399657B1 (en) 2002-06-04
IL117349A (en) 2002-09-12
NZ286107A (en) 1998-08-26
PE43597A1 (es) 1997-12-26
AR002710A1 (es) 1998-04-29
CO4370145A1 (es) 1996-10-07
NO960884L (no) 1996-09-09
JP3204901B2 (ja) 2001-09-04
GB9504460D0 (en) 1995-04-26
EE03921B1 (et) 2002-12-16
GR3034240T3 (en) 2000-12-29
NO960884D0 (no) 1996-03-05
SK29796A3 (en) 1996-10-02
IL117349A0 (en) 1996-07-23
US20030109578A1 (en) 2003-06-12

Similar Documents

Publication Publication Date Title
SV1996000015A (es) Derivados de n-(3-benzofuranil)urea
PA8463901A1 (es) Compuestos azapoliciclicos condensados con arilo
DK0944643T3 (da) Oxyiminopregnancarbolactoner.
BR0214024A (pt) Derivados de 1,2,4-tiadiazol como moduladores de receptor de melanocortina
ES2196396T3 (es) Compuestos heteroaromaticos de 5 miembros conteniendo oxigeno o azufre como inhibidores del factor xa.
ATE245977T1 (de) Therapeutische substituierte guanidine
DK1156798T3 (da) Felbamat-afledte forbindelser
BRPI0411900A (pt) compostos antivirais e métodos
ES2170884T3 (es) Acidos alfa-iminohidroxamicos y carboxilicos n-sustituidos, ciclicos y heterociclicos.
UY27892A1 (es) Benzoilureas heterociclicamente sustituidas, procedimiento para su preparacion y su uso como farmacos.
TR200100874T2 (tr) Simetrik ve simetrik olmayan sübstitüe edilmiş difenil üreler kullanılarak raf kinazın inhibe edilmesi
DK1413582T3 (da) Dimere pyrrolobenzodiazepiner
ECSP055701A (es) Nuevos derivados de pirimidinamida y el uso de los mismos
PA8489701A1 (es) Ureas difenil-(w-carboxiaril substituidas como inhibidores de raf quinasa
DOP2002000447A (es) 1-alquil o 1-cicloalquiltriazolo [4,3-a] quinazolin-5 onas como inhibidores de fosfodiesterasas
ES2159342T3 (es) Clorhidrato cristalino de (r)-(-)-2-(n-(4-(1,1-dioxido-3-oxo-2,3-dihidro-benzisotiazol-2-il)-butil)-aminometil)-cromano.
TR199801753T2 (xx) Pirimido(5,4-D) pirimidin bile�imini i�eren ila�lar, kullan�mlar� ve �retim i�lemleri.
PT1028950E (pt) Quinazolina-2,4-dionas 7-substituidas uteis como agentes antibacterianos
EA200000320A1 (ru) Изохинолины в качестве ингибиторов урокиназы
TR200000907T2 (tr) Nötrofil elastaz inhibitörleri olarak pirolopirolon türevleri.
NO975679L (no) Fremgangsmåte for fremstilling av N-monosubstituerte og N,N'-disubstituerte, usymmetriske, cykliske ureaer
DE69430902T2 (de) C2-Taxan-Derivate sowie diese enthaltende Arzneimittel
MX9304626A (es) Derivados heterociclicos utiles en el tratamiento de enfermedades cardiovasculares.
TR199701298T1 (xx) Tetralinler.
ATE115131T1 (de) Harnstoff- und thioharnstoffderivate, herstellung und therapeutische verwendung.